机构 发表于 2025-3-23 13:31:55

g on the development of personalized medicine in several areas of human health. The topics covered range from metabolic and neurological disorders to non-communicable as well as infectious diseases, and even ex978-81-322-2876-9978-81-322-1184-6

NOVA 发表于 2025-3-23 15:03:07

http://reply.papertrans.cn/71/7010/700921/700921_12.png

Urea508 发表于 2025-3-23 21:05:55

http://reply.papertrans.cn/71/7010/700921/700921_13.png

采纳 发表于 2025-3-24 02:05:18

Melvin George MD., DM.,Sandhiya Selvarajan,Suresh Kumar Srinivasamurthy

Harrowing 发表于 2025-3-24 05:00:13

http://reply.papertrans.cn/71/7010/700921/700921_15.png

Fillet,Filet 发表于 2025-3-24 06:47:14

http://reply.papertrans.cn/71/7010/700921/700921_16.png

臭了生气 发表于 2025-3-24 13:42:17

Next-Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Meng technology. NGS is revolutionizing pharmacogenomics and personalized medicine, with several NGS platforms commercially available. Illumina, Roche 454, and Applied Biosystems are the current major vendors. This chapter will characterize the technical assessments of NGS, including comparative analy

得意牛 发表于 2025-3-24 18:41:20

http://reply.papertrans.cn/71/7010/700921/700921_18.png

parsimony 发表于 2025-3-24 21:32:37

Omics Approaches and Applications in Clinical Trialsce of severe drug reactions and better clinical outcome in susceptible patients, is one of the few examples of use of genomics in the area of health care. Pharmacogenomics identifies safety biomarkers and provides an opportunity to rescue a compound that would otherwise fail to be commercialized due

MERIT 发表于 2025-3-25 00:59:16

http://reply.papertrans.cn/71/7010/700921/700921_20.png
页: 1 [2] 3 4 5 6
查看完整版本: Titlebook: Omics for Personalized Medicine; Debmalya Barh,Dipali Dhawan,Nirmal Kumar Ganguly Book 2013 Springer India 2013 Genotype.Nutrition.Pharmac